These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7254594)

  • 1. [Perfusion of the common bile duct with ursacholic acid in the treatment of residual calculi].
    Berretta S
    Minerva Dietol Gastroenterol; 1981; 27(1):11-6. PubMed ID: 7254594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemical treatment of gallbladder and bile duct calculi. Current status and critical comment].
    Leuschner U
    Med Klin (Munich); 1986 Mar; 81(6):217-22. PubMed ID: 3785080
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experiences concerning gallstones dissolution with ursodeoxycholic acid.
    Canepa A; Volpi C; Ciravegna G; Dodero M; Celle G
    Acta Gastroenterol Belg; 1980; 43(11-12):502-7. PubMed ID: 7211116
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical treatment of gallstones: ursodeoxycholic acid.
    Drug Ther Bull; 1984 Feb; 22(4):13-5. PubMed ID: 6705691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cholesterol gallstones with ursodesoxycholic acid (author's transl)].
    Bernades P; Bertrand L; Bouvry M; Colin R; Geffroy Y; Hecht Y; Klepping C; Lambert R; Levy VG; Michel H; Paliard P; Paris J; Quinton A
    Nouv Presse Med; 1982 Feb; 11(8):587-9. PubMed ID: 7041086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating treatment of common bile duct stones with a modified glyceryl-1-monooctanoate preparation and a bile acid-EDTA solution by nasobiliary tube.
    Leuschner U; Wurbs D; Baumgärtel H; Helm EB; Classen M
    Scand J Gastroenterol; 1981; 16(4):497-503. PubMed ID: 6798685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of biliary lithiasis with ursodeoxycholic acid].
    Delmont J; Rampal P; Math M; Faure X; Renson M
    Sem Hop; 1980 Oct 18-25; 56(39-40):1613-6. PubMed ID: 6255580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biliary periodicity. The value of ursolvan 200 mg].
    Med Chir Dig; 1981; 10(3):285-6. PubMed ID: 7266139
    [No Abstract]   [Full Text] [Related]  

  • 11. Ursodeoxycholic acid and bile hypersaturation.
    Garrido-Palma G; Berenguer-Lapuerta J; Bretó-Gilabert M
    Dig Dis Sci; 1984 Apr; 29(4):380. PubMed ID: 6705653
    [No Abstract]   [Full Text] [Related]  

  • 12. Micellar solubilization of intestinal lipids after ursodeoxycholic acid therapy in short bowel patients and healthy controls.
    Huijbregts AW; Cox TM; Hermsen J; van Berge Henegouwen GP; van Schaik A; Chadwick VS
    Neth J Med; 1981; 24(3):108-13. PubMed ID: 7254441
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatment of gallstones.
    Iser J
    Aust Fam Physician; 1981 Jun; 10(6):492-4. PubMed ID: 7283856
    [No Abstract]   [Full Text] [Related]  

  • 14. [The dissolution of residual calculi in the common bile duct using chenodeoxycholic acid (author's transl)].
    Pelissier E; Carayon P; Spitz JF
    Chirurgie; 1978; 104(8):775-9. PubMed ID: 747970
    [No Abstract]   [Full Text] [Related]  

  • 15. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Further progress in the pharmacological dissolution of biliary calculi with ursodeoxycholic acid].
    Bojanowicz K; Witkowska A
    Wiad Lek; 1981 Aug; 34(16):1363-7. PubMed ID: 7340149
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport.
    Dumont M; Erlinger S; Uchman S
    Gastroenterology; 1980 Jul; 79(1):82-9. PubMed ID: 7380227
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.